Jaka jest cena za RepliCel Life Sciences Inc. (RP)

Cena za RepliCel Life Sciences Inc. (RP) wynosi $0.01100905

Jaka jest kapitalizacja rynkowa dla RepliCel Life Sciences Inc. (RP)

Kapitalizacja rynkowa dla RepliCel Life Sciences Inc. (RP) wynosi $810.02K

RepliCel Life Sciences Inc. (RP) Cena i Kapitalizacja Rynkowa

Headquartered in Vancouver, Canada, RepliCel Life Sciences Inc. is a regenerative medicine company dedicated to developing innovative autologous cell therapies. These treatments are designed to correct functional cellular deficiencies by harnessing a patient's own cells. The process involves isolating cells from harvested tissues, significantly expanding them in a controlled laboratory environment, and subsequently applying them therapeutically. The company's developmental portfolio includes several key product candidates: RCT-01 targets chronic tendinosis, RCS-01 addresses aging and sun-damaged skin, and RCH-01 is aimed at treating hair loss. Additionally, RepliCel is advancing RCI-02, a specialized dermal injection device. RepliCel has established significant strategic alliances. It holds a collaboration and technology transfer agreement with YOFOTO (China) Health Industry Co. Ltd. to establish a clinical research program and facilitate the commercialization of RCS-01 and RCT-01. A similar collaboration exists with Shiseido Company, Limited, focusing on the clinical research program for RCH-01. Furthermore, the company is engaged in a research project agreement with the University of British Columbia, contributing to the creation of a comprehensive hair follicle cell data map.

Cena za RP	Aktywa B	Kapitalizacja rynkowa B	Wyniki
$73,988.51 $810.02K	NVDA	$5.444T	+672,069,588.97%
$60,940.98 $810.02K	AAPL	$4.484T	+553,553,177.88%
$56,627.11 $810.02K	GOOG	$4.166T	+514,368,450.41%
$50,289.47 $810.02K	MSFT	$3.700T	+456,800,954.63%
$38,579.35 $810.02K	AMZN	$2.839T	+350,432,828.17%

Cena za RP

Aktywa B

Kapitalizacja rynkowa B

Wyniki

$73,988.51 $810.02K